These findings suggest that LARP6 may play a dual role in breast cancer progression—directly promoting cancer cell proliferation through cell cycle regulation as demonstrated in our functional studies, while simultaneously modulating the tumour immune microenvironment. Here, LARP6 is linked to neoplasm.